Patents Assigned to Fibralign Corporation
  • Patent number: 11273235
    Abstract: Materials and methods are provided to direct the formation of new lymphatics and to reconnect the disrupted lymphatic network. These materials and methods enable to improve survival of lymph nodes and lymph node fragments and their integration into a lymphatic network, following lymph node and lymph node fragments transplantation. The treatment or prevention of lymphedema is also addressed. In certain embodiments, a bundle of fibers or fibrils presented in the composition is effective to stimulate and direct the formation of new lymphatic and blood vessels. The bundle of fibers or fibrils presented in the composition is effective to promote survival of the lymph node or lymph node fragments and integration of the lymph node or lymph node fragments into a lymphatic network in the mammalian subject, at the site of transfer or transplantation.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: March 15, 2022
    Assignee: Fibralign Corporation
    Inventors: Catarina Hadamitzky, Tatiana Zaitseva, Michael V. Paukshto
  • Patent number: 11013826
    Abstract: In general, the present invention is related to biopolymer and biocomposite materials and structures, and methods of making and using the same. In some embodiments, the present invention is directed to oriented collagen based biocomposite materials and structures, and methods of making.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: May 25, 2021
    Assignee: Fibralign Corporation
    Inventors: Mikhail Vitoldovich Paukshto, David Harwood McMurtry, Tatiana Zaitseva
  • Patent number: 10639450
    Abstract: A novel medical device and a method for delivery of a scaffold for treatment of secondary lymphedema and ischemia is provided. In some embodiments a catheter medical device and a magnetic guidance method are provided for delivering cell-seeded implants for guided lymphatic regeneration.
    Type: Grant
    Filed: July 24, 2013
    Date of Patent: May 5, 2020
    Assignee: FIBRALIGN CORPORATION
    Inventors: David H. McMurtry, Michael V. Paukshto, Tatiana S. Zaitseva
  • Patent number: 10238769
    Abstract: Embodiments of the present invention relate to a therapeutic device (graft) comprising a collagen membrane having an aligned uniaxial or biaxial structure such that mammalian cells plated on the membrane align mainly along the direction of the collagen fibrils. In a further aspect, a graft comprising a substantially tubular body, wherein the body has an exterior surface, an interior surface, and at least one lumen extending therethrough such that a fluid flow through the lumen can direct mammalian cell migration. In a further aspect, mammalian cells or growth and angiogenic factors can be optionally attached to the exterior and/or interior surface of the substantially tubular body. In various aspects, the graft can be used as a vascular prosthesis, a stent, or a nerve regeneration scaffold. Methods of preparing and implanting same are also provided.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: March 26, 2019
    Assignees: Fibralign Corporation, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Michael V. Paukshto, John P. Cooke, Tatiana S. Zaitseva, Ngan F. Huang, Gerald G. Fuller, George R. Martin
  • Patent number: 10086079
    Abstract: In general, the present invention is related to biopolymer and biocomposite materials and structures, and methods of making and using the same. In some embodiments, the present invention is directed to oriented collagen based biocomposite materials and structures, and methods of making.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: October 2, 2018
    Assignee: Fibralign Corporation
    Inventors: Mikhail Vitoldovich Paukshto, David Harwood McMurtry, George R. Martin, Tatiana Zaitseva
  • Patent number: 10065046
    Abstract: Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically, embodiments of the present invention relate to medical devices, materials or constructs, such as conductive biocompatible polymers having one or more networks of metal nanowires that enhance tissue repair and regeneration using electromagnetic fields.
    Type: Grant
    Filed: July 15, 2011
    Date of Patent: September 4, 2018
    Assignee: Fibralign Corporation
    Inventors: Michael Paukshto, George Martin, John Cooke
  • Patent number: 9724308
    Abstract: Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically embodiments of present disclosure relate to devices or constructs and methods to prepare various devices or constructs useful in directing cellular repair and controlling tissue regeneration to prevent or minimize postsurgical or post traumatic adhesions, excessive scars and/or fibrotic reactions of injured tissues.
    Type: Grant
    Filed: September 10, 2011
    Date of Patent: August 8, 2017
    Assignee: Fibralign Corporation
    Inventors: Michael V. Paukshto, George R. Martin, David H. McMurtry
  • Publication number: 20140081070
    Abstract: Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically embodiments of present disclosure relate to devices or constructs and methods to prepare various devices or constructs useful in directing cellular repair and controlling tissue regeneration to prevent or minimize postsurgical or post traumatic adhesions, excessive scars and/or fibrotic reactions of injured tissues.
    Type: Application
    Filed: September 10, 2011
    Publication date: March 20, 2014
    Applicant: FIBRALIGN CORPORATION
    Inventors: Michael V. Paukshto, George R. Martin, David H. McMurtry
  • Publication number: 20130287744
    Abstract: In general, the present invention is related to biopolymer and biocomposite materials and structures, and methods of making and using the same. In some embodiments, the present invention is directed to oriented collagen based biocomposite materials and structures, and methods of making.
    Type: Application
    Filed: June 24, 2013
    Publication date: October 31, 2013
    Applicant: Fibralign Corporation
    Inventors: Mikhail Vitoldovich Paukshto, David Harwood McMurtry, George R. Martin, Tatiana Zaitseva
  • Patent number: 8513382
    Abstract: In general, the present invention is related to biopolymer and biocomposite materials and structures, and methods of making and using the same. In some embodiments, the present invention is directed to oriented collagen based biocomposite materials and structures, and methods of making.
    Type: Grant
    Filed: August 11, 2009
    Date of Patent: August 20, 2013
    Assignee: Fibralign Corporation
    Inventors: Mikhail Vitoldovich Paukshto, David Harwood McMurtry, George R. Martin, Tatiana Zaitseva, Yuri Alexandrovich Bobrov
  • Patent number: 8492332
    Abstract: In general, the present invention is related to collagen compositions and thin films, and to methods of making and using the same. In some embodiments, the present invention is directed to “uniaxial pattern” or “linear pattern” collagen materials, compositions and thin films, and methods of making.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: July 23, 2013
    Assignee: Fibralign Corporation
    Inventors: Mikhail Vitoldovich Paukshto, David Harwood McMurtry, Yuri Alexandrovich Bobrov, Eric Eugene Sabelman
  • Patent number: 8227574
    Abstract: In general, the present invention is related to collagen compositions and thin films, and to methods of making and using the same. In some embodiments, the present invention is directed to “woven pattern” or “basket pattern” collagen compositions and thin films, and methods of making.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: July 24, 2012
    Assignees: Fibralign Corporation, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Mikhail Vitoldovich Paukshto, David Harwood McMurtry, Gerald G. Fuller, Yuri Alexandrovich Bobrov, John E. Kirkwood
  • Publication number: 20120065703
    Abstract: Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically, embodiments of the present invention relate to medical devices, materials or constructs, such as conductive biocompatible polymers having one or more networks of metal nanowires that enhance tissue repair and regeneration using electromagnetic fields.
    Type: Application
    Filed: July 15, 2011
    Publication date: March 15, 2012
    Applicant: Fibralign Corporation
    Inventors: Michael Paukshto, George Martin, John Cooke
  • Patent number: 8028647
    Abstract: A liquid coating applicator with a very precise means for controlling gap thickness as well as adapting to non-planar discontinuities in the substrate.
    Type: Grant
    Filed: November 20, 2007
    Date of Patent: October 4, 2011
    Assignee: Fibralign Corporation
    Inventors: David Harwood McMurtry, Mikhail Vitoldovich Paukshto, Yuri A. Bobrov